Increased utilization of primary care 5 years before diagnosis of type 2 diabetes: A matched cohort study

Diabetes Care

Volumn 28, Issue 1, 2005, Pages 47-52

  Gulliford, Martin C ^a   Charlton, Judith ^a   Latinovic, Radoslav ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; INSULIN; METFORMIN; ORAL ANTIDIABETIC AGENT; SULFONYLUREA;

ADULT; AGED; ARTICLE; CONSULTATION; CONTROLLED STUDY; DRUG UTILIZATION; FEMALE; HUMAN; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRESCRIPTION; PRIMARY MEDICAL CARE; STROKE;

COHORT STUDIES; DATABASES, FACTUAL; DIABETES MELLITUS, TYPE 2; FAMILY PRACTICE; FEMALE; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; PREDIABETIC STATE; REFERENCE VALUES; REFERRAL AND CONSULTATION; TIME FACTORS;

EID: 11844260637     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.28.1.47     Document Type: Article

References (25)

1. Centers for Disease Control and Prevention: Prevalence of diabetes and impaired fasting glucose in adults: United States, 1999-2000. MMWR Morb Mortal Wkly Rep 52:833-837, 2003
2. Fontaine KR, Redden DT, Wang C, Westfall AO, Allison DB: Years of life lost due to obesity. JAMA 289:187-193, 2003
3. Kohner EM, Aldington SJ, Stratton IM, Manley SE, Holman RR, Matthews DR, Turner RC: United Kingdom Prospective Diabetes Study, 30: diabetic retinopathy at diagnosis of noninsulin-dependent diabetes mellitus and associated risk factors. Arch Ophthalmol 116:297-303, 1998
4. Harris MI, Klein R, Welborn TA, Knuiman MW: Onset of NIDDM occurs at least 4-7 years before clinical diagnosis. Diabetes Care 15:815-819, 1992
5. UK Prospective Diabetes Study Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 352:837-853, 1998
6. UK Prospective Diabetes Study Group: Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes. BMJ 317:703-713, 1998
7. Collins R, Armitage J, Parish S, Sleigh P, Peto R, Heart Protection Study Collaborative Group: MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet 361:2005-2016, 2003
8. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM, Diabetes Prevention Program Research Group: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393-403, 2002
9. American Diabetes Association and National Institute of Diabetes, Digestive and Kidney Diseases: The prevention or delay of type 2 diabetes. Diabetes Care 25:742-749, 2002
10. Wylie G, Hungin AP, Neely J: Impaired glucose tolerance: qualitative and quantitative study of general practitioners' knowledge and perceptions (Letter). BMJ 324:1190, 2002
11. Hollowell J: The General Practice Research Database: quality of morbidity data. Popul Trends 87:36-40, 1997
12. NHS Information Authority: Clinical terms (Read codes): summarized product description. Birmingham, U.K., 2004. Accessed 12 July 2004. Available from: http://www.nhsia.nhs.uk/terms/pages/readcodes_ pfd/summar.asp
13. National statistics: Key Health Statistics From General Practice 1998. London, National Statistics, 2000 (Series MB6 no. 2)
14. British Medical Association and Royal Pharmaceutical Society of Great Britain: British National Formulary no. 47, London, 2004. Accessed 1 September 2004. Available from: http://www.bnf.org
15. Cummings P, McKnight B, Greenland S: Matched cohort methods for injury research. Epidemiol Rev 25:43-50, 2003
16. Stata Corporation: Stata Reference Manual Release 7. College Station, Texas, Stata Corporation, 2001
17. Nichols GA, Brown JB: Unadjusted and adjusted prevalence of diagnosed depression in type 2 diabetes. Diabetes Care 26:744-749, 2003
18. Rimm EB, Chan J, Stampfer MJ, Colditz GA, Willett WC: Prospective study of cigarette smoking, alcohol use, and the risk of diabetes in men. BMJ 310:555-559, 1999
19. van Doorslaer E, Wagstaff A, van der Burg H, Christiansen T, De Graeve D, Duchesnse I: Equity in the delivery of health care in Europe and the US. J Health Economics 19:553-583, 2000
20. Erens B, Primatesta P: Health Survey for England 1998: Cardiovascular disease. Vol. 1: Findings. London, the Stationery Office, 1999. Accessed 1 September 2004. Available from: http://www.archive.official-documents.co.uk/ document/doh/survey98/hse98.htm
21. Nichols GA, Glauber HS, Brown JB: Type 2 diabetes: incremental medical care costs during the 8 years preceding diagnosis. Diabetes Care 23:1654-1659, 2000
22. Haffner SM: Pre-diabetes, insulin resistance, inflammation and CVD risk. Diabetes Res Clin Pract 61 (Suppl. 1):S9-S18, 2003
23. Hu FB, Stampfer MJ, Haffner SM, Solomon CG, Willett WC, Manson JE: Elevated risk of cardiovascular disease prior to clinical diagnosis of type 2 diabetes. Diabetes Care 25:1129-1134, 2002
24. Spijkerman AMW, Yuyun MF, Griffin SJ, Dekker JM, Nijpels G, Wareham NJ: The performance of a risk score as a screening test for undiagnosed hyperglycemia in ethnic minority groups: data from the 1999 Health Survey for England. Diabetes Care 27:116-122, 2004
25. Zhang P, Engelgau MM, Valdez R, Benjamin SM, Cadwell B, Venkat Narayan KM: Costs of screening for pre-diabetes among U.S. adults: a comparison of different screening strategies. Diabetes Care 26:2536-2542, 2003